Dr. Todd Ridky
Todd Ridky, MD and a group at Stanford, were able to transform several human epithelial cells into [MORE]
In the transition of loose connective tissue, known as mesenchyme, into epithelial cells of the lung, DNA methylation can silence [MORE]
Cancer patients usually present multiple secondary symptoms, such as depression, fatigue, difficulty sleeping, joint and back pain, nausea and dry [MORE]
Chip to Capture Cancer Cells
Microfluidic chips have been useful in capturing biomarkers and pathogens, but thus far they haven’t [MORE]
Liver Cancer Care
Earlier this year, Pfizer, Eli Lilly, and Merck agreed to create a nonprofit Asian Cancer Research Group [MORE]
Imagine the sign on the door: “California NanoSystems Institute: Nano Machine Center for Targeted Delivery and On-Demand Release.” [MORE]
Most of the R&D work on induced pluripotent stem cells has been done with skin tissue, but recently, investigators at [MORE]
Melanoma
Using a hand-held six light device, researchers at the Machine Vision Laboratory (Bristol Institute of Technology, Bristol, UK) are [MORE]
Protein scientists in Germany and Japan have developed a new biochip that can detect proteins for specific diseases and [MORE]
Dr. Gerd Binning
Royal Philips Electonics, in the Netherlands, and Munich-based Definiens have signed an agreement to pursue molecular imaging. [MORE]
A recent study reported on the importance of DNA copy number variations-both duplications and deletions on chromosomes-in causing cancers. Indeed, [MORE]
As an indication of things to come, Qiagen (Venlo, The Netherlands) signed an exclusive agreement with Johns Hopkins [MORE]
Dr. Victor Veulescu in his lab at Johns Hopkins
Residual cancer, after surgery, leaves biomakers in the blood-both protein and [MORE]
It’s not surprising that in searching for genomic individuality, researchers would find pathway-exhibiting cohorts based on age and gender. Still, [MORE]